Spider Silk & Crypto-Powered Rebrands Signal a New Investor Web

September 19, 2025

DENVER, Colo., Sep 19, 2025 (247marketnews.com)- Kraig Biocraft Laboratories (OTCQB:KBLB) climbed higher in early trading after announcing its plans to acquire an additional silkworm rearing center as part of a broader multi-facility expansion. The company has rapidly scaled production under sericulture veteran Dr. Nirmal Kumar, positioning its recombinant spider silk as a next-gen material for defense, textiles, and sustainability sectors.

“The progress we’ve made in expanding our production platform has exceeded expectations,” said CEO Kim Thompson. With the growing appetite for biodegradable super-materials, KBLB continues spinning a compelling growth narrative.

Millennium International (NASDAQ:MIHI) is gaining attention on social media and trader forums after investors spotted unusual volume spikes. While its rumored expansion into the Middle East’s ecommerce and logistics sector has reignited speculation that a regional JV or acquisition may be in the works.

Verrica Pharmaceuticals (NASDAQ:VRCA) saw modest gains after a recent update in its investor presentation suggested commercial traction is building for YCANTH, its FDA-approved topical for molluscum contagiosum. As school season ramps up, analysts anticipate higher demand for pediatric skin treatments, which could offer upside in Q4 guidance revisions.

Sow Good (NASDAQ:SOWG), the freeze-dried snack and nutrition disruptor, announced that it has doubled its direct-to-consumer (DTC) revenue year-over-year and is expanding its Amazon footprint. The company is also exploring international distribution as it eyes the booming global wellness market. With strong margins and brand traction, SOWG is being quietly added to some microcap growth watchlists.

Wearable Devices (NASDAQ:WLDS) is trending higher this morning as interest in AI-driven gesture control continues to gain steam following Apple’s recent Vision Pro developer updates. WLDS’s neural input interface, designed for AR/VR and consumer electronics, could be a sleeper beneficiary in the wearable tech space. The company has also teased a new OEM partnership announcement for Q4.

ALT5 Sigma (NASDAQ:ALTS) is back in the spotlight after blockchain influencers highlighted its institutional-grade crypto trading platform as a potential acquisition target in Canada’s consolidating fintech sector. With increased regulatory scrutiny of offshore exchanges, ALT5’s compliant infrastructure is a growing asset.

Adaptimmune Therapeutics (NASDAQ:ADAP) is staging a technical rebound after a tough selloff earlier this year. The company’s TCR T-cell therapies for solid tumors remain promising, with upcoming readouts expected at major oncology conferences.

PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 247 is a third-party media provider and has been compensated by one or more featured companies for providing ongoing KBLB market outreach and other services.. This press release may include technical analysis and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions. Please review 247’s Full Disclaimer https://www.247marketnews.com/disclaimer/. Please go to https://247marketnews.com/kblb-disclosure/ for further KBLB and 247marketnews.com disclosure information.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (KBLB, MIHI, VRCA, SOWG, WLDS, ALTS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.